Analysis of Drug-Related Problems in Benign Prostatic Hyperplasia (BPH) Patients at Arifin Achmad Hospital, Riau Province
Abstract
Keywords
Full Text:
PDFReferences
Singapore Urological Association Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Guidelines Committee 2015. Singapore Urological Association Clinical Guidelines for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia. Singapore Med J. 2017. 58(8): 473-480.
Yeo JK, Choo H, Bai JH, Ok Yang S, Young Oh C, Sam Cho Y, et al. Korean clinical practice guideline for benign prostatic hyperplasia.Investig Clin Urol; 2016. 57:30-44
Foppe van Mill JW, Horvet N, and Westerlund T. Classification of Drug-Related Problem V9.00. Pharmaceutical Care Network Europe Foundation. 2019.
Dahlan MS.Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian Kedokteran dan Kesehatan. Edisi 3. Jakarta: Salemba Medika. 2010
Roveny. Terapi Farmakologis Hiperplasia Prostat Jinak. CDK.2016. 239. Vol. 43.No.4.
Lokeshwar SD, Harper BT, Webb E, Jordan A, Dykes TA, Neal Jr DE et al. Epidemiology and treatment modalities for the management of benign prostatic hyperplasia.TranslAndrolUrol.2019.8(5):529-39.
Andriani R, Karsana AAR, dan Satyaweni IGA. Pengaruh Pemberian Asuhan Kefarmasian Terhadap Kejadian Permasalahan Terkait Obat Pasien Geriatri Rawat Inap di RSUP Sanglah Denpasar. PHARMACEUTICAL JOURNAL OF INDONESIA. 2019. 4(2): 79 83
Foppe van Mill JW, Horvet N, and Westerlund T. Classification of Drug-Related Problem V5.01. Pharmaceutical Care Network Europe Foundation.2006.
Mohammed S, Poudel S, Laloo F, Madhur A, Robert R, and Mathew B. Assessment of Drug Related Problems in a Tertiary Care Teaching Hospital, India. Asian J Pharm Clin Res. 2017.Vol 10, Issue 2: 310-3.
Greeshma M, Lincy S, Maheswari E, Tharanath S, and Viswam S. Identification of Drug Related Problems by Clinical Pharmacist in Prescriptions with Polypharmacy: A Prospective Interventional Study. J Young Pharm. 2018; 10(4): 460-65.
Garedow AW, Bobasa EM, Wolide AD, Dibaba FK, Fufa FG, Tufa BI, et al. Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study. International Journal of Nephrology.2019.
Fog AF, Kvalvaag G, Engedal K, and Straand J. Drug-related problems and changes in drug utilization after medication reviews in nursing homes in Oslo, Norway. SCANDINAVIAN JOURNAL OF PRIMARY HEALTHCARE. 2017.VOL.35, NO.4, 329-35.
Bhagavathula SA, Meknonnen BG, Birrra KM, Tekle TM. Assessment of Drug Related Problems and its Associated Factors among Medical Ward Patients in University of Gondar Teaching Hospital, Northwest Ethiopia: A Prospective Cross-Sectional Study. J Basic Clin Pharma. 2017.
Fauziah N, Ahmad I, dan Ibrahim A. Karakteristik dan Analisis Drug Related Problems (DRPs) Pasien Penderita Tuberculosis di Puskesmas Temindung Samarinda Kalimantan Timur. J. Trop. Pharm. Chem. 2014.Vol 2. No. 5.
Lim KB. Epidemiology of Clinical benign Prostatic Hyperplasia. Asian Journal of Urology. 2017. 4: 148-51
Speakman MJ, Cheng X. Management of the complications of BPH/BOO. Indian J Urol. 2014;30(2):208-13.
Kim HJ, Sun HY, Choi H, Park JY, Bae JH, Doo SW, et al. Efficacy and Safety of Initial Combination Treatment of an Alpha Blocker with an Anticholinergic Medication in Benign Prostatic Hyperplasia Patientswith Lower Urinary Tract Symptoms: Updated Meta-Analysis. PLoS ONE. 2017.
Zaman Huri H, Hui Xin C, Sulaiman CZ. Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study. PloS ONE. 2014..
Arini DY, Rahmawati F, Andayani TM. Faktor Risiko Drug Related Problems Pada Pasien Penyakit Kronis Rawat Jalan di Polikinik Penyakit Dalam. Jurnal Manajemen dan pelayanan Farmasi. 2016. Voume 6 No2.
Iyer K, Dilipkumar N, Vasaya S, Pawar S, and Diwan A. Comparison of Drug Related Problems Associated with Use of Narrow Therapeutic Index Drugs and Other Drugs in Hospitalized Patients.J Young Pharm. 2018. 10(3): 318-21.
DOI: https://doi.org/10.30596/bf.v6i2.5528
DOI (PDF): https://doi.org/10.30596/bf.v6i2.5528.g5683
Refbacks
- There are currently no refbacks.
JURNAL BULETIN FARMATERA
Gedung Kampus 1 Universitas Muhammadiyah Sumatera Utara (UMSU) Lantai II, Laboratorium Farmakologi dan Terapi Fakultas Kedokteran UMSU Jalan Gedung Arca No. 53 Medan Sumatera Utara Indonesia, Kode Pos 20217.
Contact (WA): 0812-6208-2844
E-mail: jurnalpanduhusada@umsu.ac.id
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.